易特科集团(安测健康)CEO张贯京携全体员工 祝朋友们圣诞快乐!

2020-12-24 09:28

尊敬的各届朋友:

   大家好!

   年年有圣诞,圣诞在年年,吉祥和平安,幸福加欢颜,祝福和问候,温暖来相伴,欢歌和笑语,弥漫情谊间!我们即将辞别收获满满的2020年,迎接期待多多的2021年。值此圣诞,易特科集团(安测健康)董事长兼CEO张贯京先生,向奋斗在各级岗位兢兢业业努力拼搏的全体员工及家人,向长期以来关心、支持易特科集团(安测健康)事业发展的各界朋友致以最衷心的感谢和最美好的祝福!

   谢谢公司全体团队的百折不挠、辛勤拼搏、团结协同、勇往直前和砥砺前行!感谢医学界科学界金融界合作伙伴以及客户朋友们的衷心认可和支持合作!感谢各级政府的全力支持和悉心指导!感谢清华母校及校友的合作关照以及鼎力支持!也恭祝各界朋友圣诞吉祥、 阖家欢乐、身体健康、万事如意!

   2020年,易特科集团(安测健康)创新创业度过了非凡而扎实的一年,硕果累累!

   易特科集团(安测健康)聚焦医疗信息化及医疗智能化,持续创新产品,升级了智慧健康全流程管理系统、智慧医养管理平台、智慧医院云信息系统、智慧影像辅助判读平台和智慧中医辅助辨识平台五大核心产品线,产品结构不断优化,技术优势日益凸显!

   易特科集团(安测健康)在克服年初新冠疫情困境的情况下,市场业绩稳健增长,经营效率进一步提高,安测健康产品及服务进入全国650多家公立医疗机构和450多家社康中心,产品竞争力、产品成熟度、市场接受度、品牌影响力、议价能力等方面均有了显著提升!

  在各界朋友的合作支持下,易特科集团(安测健康)不断加强关键核心技术攻关;我们作为华为全球生态合作伙伴,AI慢病管理系统入选华为云严选方案,鲲鹏云ARM架构,ISV;我们与清华大学签署智慧医疗研发创新战略合作协议;安测肺病医疗影像辅助诊断系统正多家综合医院进行合作研究,未来将全面推动我国肺癌精准医学事业发展;我们正在全力推进大湾区中医科学院建设,由院士牵头,以国医大师和科学家为核心团队,会聚国内著名中医科研院所及信息科技公司,以生命科学、信息科技、人工智能为手段,探索人体生理病理、规范中医诊断标准、提升中医诊疗水平,将创新科技融入中医,让现代中医走向世界!

   凭借在“AI+医疗、AI+健康、AI+养老”领域的高科技产品、人工智能技术、知识产权创新、产业化优势和近三年营收规模复合高速增长,易特科集团(安测健康)荣获德勤中国主办评选的2020“中国高科技高成长企业50强”与“深圳高科技高成长企业20强”、招商证券的“羚跃计划”、招商银行“新动能基金”重点推荐企业、国家知识产权优势企业、深圳质量百强企业、两项技术获第21届中国专利优秀奖,累计获得6项中国专利优秀奖,知识产权总量超过3100项、AI慢病管理系统荣获深圳市科技进步二等奖……我们的产品创新、技术创新和知识产权创新实力获得社会各界认可,创新实力在智慧医疗领域全国领先!众多荣誉奖励表明易特科集团(安测健康)强大的生产和技术研发实力在智慧医疗领域具有突出优势,品牌和产品认可度更高,为公司全力推进IPO上市奠定了技术基础与科创属性!

   上述这些成绩是公司市场团队开拓进取的结果,是研发实施团队努力拼搏的结果,也是所有支撑团队团结协作的结果,更是各界朋友鼎力支持的结果,在此致以衷心感谢!

   及时当勉励,岁月不待人。2021年我们的任务还将十分繁重艰巨、时间十分紧迫、压力十分巨大。我将带领公司全体团队,紧跟时代步伐,以最先进的人工智能、大数据、深度学习等技术和产品服务于医疗信息化、健康养老行业,通过生命科学与信息科学融合创新,提升临床医学的效率、效力和效益;公司全体团队将不断增强紧迫感,树立危机意识,面向市场努力拓展经营,全力争取经营效益提升,争取快速迈进IPO

易特科集团(安测健康)一直强调踏踏实实的务实精神,坚持“感恩、责任、勤勉、分享”的企业文化,希望2021年,我们全体团队不忘初心,倾洪荒之力,在AI+医疗+健康+养老行业砥砺前行,以国家医疗健康政策为指南,以全国市场的全速发展为依托,以人工智能技术的全面创新为导向,努力奋斗,再创佳绩,争做国内行业细分领域的领航者与独角兽,努力实现人类健康梦,易特科的中国梦!

    再次恭祝各界朋友圣诞吉祥、 阖家欢乐、身体健康、万事如意!


易特科集团(安测健康)CEO张贯京

写于2021圣诞前夜


Dear friends,

      We are about to bid farewell to the year 2020, which is full of harvest, and welcome to 2021, which is full of expectations. On this Christmas, Mr. Zhang Guanjing, Chairman and CEO of E-Techco Group (Anycheck Health), to all employees and family who are struggling to work hard, to all walks of life who have been concerned and supported the development of E-Techco Group Friends send their most sincere thanks and best wishes.

 Thank the entire team of the company for its indomitableness, hard work, unity and cooperation, forge ahead and forge ahead! Thanks to the medical and scientific financial partners and customers for their sincere recognition and support of cooperation! Thank you for your support and guidance! Thanks Tsinghua University and alumni for their cooperation and support! Wish all our friends from all walks of life, happy New Year, happy family, good health and good luck!

      In 2020, E-Techco Group ( Anycheck Health) spent an extraordinary and solid year in innovation and entrepreneurship, with great results!

  E-Techco Group focuses on medical informatization and medical intelligence, and continues to innovate products. It has upgraded the five major processes of smart health management system, smart hospital cloud information system, smart image- aided interpretation platform, smart TCM-aided identification platform, and AI pathology-assisted diagnostic platform. The core product line, the product structure is constantly optimized, and the technical advantages are increasingly prominent.

 Under the situation of overcoming the plight of new epidemic, the market performance of E-Techco Group ( Anycheck Health) has been steadily increased, and the business efficiency has been further improved. Products and services have entered more than 650 public medical institutions and more than 450 social health centers in China. The product competitiveness, product maturity, market acceptance, brand influence and bargaining power have been significantly improved!

   With the cooperation and support of friends from all walks of life, E-Techco Group has continuously strengthened key technology research. As a global ecological partner of Huawei, our AI chronic disease management system has been selected into the Huawei Cloud Strict Selection Program, Kunpeng Cloud ARM Architecture, ISV; we have worked with Tsinghua University signed a smart medical research and development and innovation strategic cooperation agreement; Antest Pulmonary Medical Imaging Assisted Diagnostic System is conducting cooperative research in a number of general hospitals, and will comprehensively promote the development of precision medicine for lung cancer in China in the future; Led by academicians, with Chinese medicine masters and scientists as the core team, they gathered well-known domestic Chinese medical research institutes and information technology companies to explore human physiology and pathology, standardize TCM diagnostic standards, and improve TCM diagnosis and treatment by means of life sciences, information technology, and artificial intelligence, integrate innovative technology into Chinese medicine, and let modern Chinese medicine spread to the world.

      With the high-tech products, AI technology, intellectual property innovation, industrialization advantages and the compound rapid growth of revenue scale in recent three years in the field of "AI + Medical, AI + Health, AI + Pension", E-Techco Group won the 2020 "top 50 high-tech enterprises in China" , "top 20 high-tech high-growth enterprises in Shenzhen" sponsored by Deloitte & Touche, "Lingyue plan" of China Merchants Bank, "new kinetic energy fund" key recommended enterprises, national intellectual property advantage enterprises, Shenzhen top 100 quality enterprises, two China Patent Excellence Awards. AI chronic disease management system won the second prize of Shenzhen Science and technology progress. Our product innovation, technological innovation and intellectual property innovation strength has been recognized by all sectors of the society, and our innovation strength is leading in the field of intelligent medical treatment in China! Many honorary awards show that the strong production and technology R & D strength of E-Techco Group ( Anycheck Health) has outstanding advantages in the field of intelligent medical treatment, with higher brand and product recognition, which has laid a technical foundation and scientific innovation attribute for the company's full promotion of IPO listing!

  These achievements are the result of the company's market team's pioneering and enterprising efforts, the results of the R & D and implementation team's hard work, the results of the solidarity and cooperation of all support teams, and the support of friends from all walks of life.

 In 2021, our task will be very heavy, the time is very urgent, and the pressure is very great. I will lead the company's entire team to keep pace with the times, serve the medical informatization and health care industry with the most advanced technologies and products such as artificial intelligence, big data, and deep learning. Through the integration and innovation of life sciences and information science, improve clinical medicine effectiveness, efficiency and benefits; the entire team of the company will continue to increase the sense of urgency, establish a sense of crisis, work hard to expand operations towards the market, and strive to improve the operating efficiency, and strive for a rapid IPO!

      E-Techco Group ( Anycheck Health) has always stressed the down-to-earth spirit and the corporate culture of "gratitude, responsibility, diligence and sharing". It is hoped that in 2021, our whole team will not forget their original intention and spare no effort to forge ahead in the AI + Medical + Health + Pension industry, with the national health policy as the guide, the full speed development of the national market as the basis, and artificial intelligence as the basis Guided by the comprehensive innovation of technology, we strive to be the leader and unicorn of domestic industry segmentation, and strive to realize the dream of human health and the Chinese dream of E-Techco!

   I wish all friends a happy Christmas, good health and all the best!

 

E-Techco CEO Zhang Guanjing